Clinical Trial Update: Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the effects of dapagliflozin on hyperlipidemia and insulin resistance in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Osaka University | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN